Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010678

Executive Vice President gave up 134,481 shares (to pay taxes)

  • Executive Vice President acquired 262,911 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shah Nikita Executive Vice President 2025-03-03 Option exercise +36,232 345,871 D
Shah Nikita Executive Vice President 2025-03-03 Shares withheld for taxes −18,533 $8.76 $162,349 327,338 D
Shah Nikita Executive Vice President 2025-03-03 Option exercise +45,872 373,210 D
Shah Nikita Executive Vice President 2025-03-03 Shares withheld for taxes −23,464 $8.76 $205,545 349,746 D
Shah Nikita Executive Vice President 2025-03-03 Option exercise +144,928 494,674 D
Shah Nikita Executive Vice President 2025-03-03 Shares withheld for taxes −74,131 $8.76 $649,388 420,543 D
Shah Nikita Executive Vice President 2025-03-04 Option exercise +35,879 456,422 D
Shah Nikita Executive Vice President 2025-03-04 Shares withheld for taxes −18,353 $8.84 $162,241 438,069 D
Derivatives
Shah Nikita Executive Vice President 2025-03-03 Option exercise · Restricted Stock Units −36,232 36,232 D
Shah Nikita Executive Vice President 2025-03-03 Option exercise · Restricted Stock Units −45,872 91,743 D
Shah Nikita Executive Vice President 2025-03-03 Option exercise · Performance-Based Restricted Stock Units −144,928 0 D
Shah Nikita Executive Vice President 2025-03-03 Grant or award · Performance-Based Restricted Stock Units +188,356 188,356 D
Shah Nikita Executive Vice President 2025-03-03 Grant or award · Restricted Stock Units +94,178 94,178 D
Shah Nikita Executive Vice President 2025-03-04 Option exercise · Restricted Stock Units +35,879 107,640 D
Loading xslF345X05/wk-form4_1741219884.xml…